<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1109234167
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DOMPY 0.1% ORAL SUSPENTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DOMPERIDONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A03FA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of your medicine is Dompy&trade; 1mg/ml Oral Suspension (called Dompy&trade; in this<br />leaflet). The active ingredient in this medicine is called domperidone. This belongs to a group of<br />medicines called &lsquo;dopamine antagonists&rsquo;.<br />This medicine is used to treat nausea (feeling sick) and vomiting (being sick) in adults and<br />adolescents (12 years of age and older and weighing 35kg or more).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Dompy&trade; if:<br />&bull; You are allergic (hypersensitive) to domperidone or any of the other ingredients of Dompy&trade;<br />1mg/ml Oral Suspension (listed in section 6: Further information). Signs of an allergic reaction<br />include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.<br />&bull; You have a tumour of the pituitary gland (prolactinoma).<br />&bull; You have a blockage or tear in your intestines.<br />&bull; You have black, tarry bowel motions (stools) or notice blood in your bowel motions. This<br />could be a sign of bleeding in the stomach or intestines.<br />&bull; You have a moderate or severe liver disease<br />&bull; You ECG (electrocardiogram) shows a heart problem called &ldquo;prolonged QT corrected<br />interval&rdquo;<br />&bull; You have or had a problem where your heart cannot pump the blood round your body as well<br />as it should (condition called heart failure)<br />&bull; You have a problem that gives you a low level of potassium or magnesium, or a high level of<br />potassium in your blood<br />&bull; You are taking certain medicines (see &ldquo;Taking other medicines&rdquo;)<br />Do not take Dompy&trade; if any of the above applies to you. If you are not sure, talk to your doctor<br />or pharmacist before taking Dompy&trade;.<br />Warnings and precautions<br />Before taking this medicine contact your doctor if you:<br />&bull; suffer from liver problems (liver function impairment or failure) (see &ldquo;Do not take Dompy&trade; if<br />you: &rdquo;)<br />&bull; suffer from kidney problems (kidney function impairment or failure).<br />It is advisable to ask your doctor for advice in case of prolonged treatment as you may need to<br />take a lower dose or take this medicine less often, and your doctor may want to examine you<br />regularly<br />&bull; are taking a medicine called levodopa, see &lsquo;Taking other medicines&rsquo;.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before<br />taking Dompy&trade;. Do this even if they have applied in the past.<br />Dompy&trade; Suspension may be associated with an increased risk of heart rhythm disorder and<br />cardiac arrest. This risk may be more likely in those over 60 years old or taking doses higher<br />than 30 mg per day. The risk also increases when Dompy&trade; is given together with some drugs.<br />Tell your doctor or pharmacist if you are taking drugs to treat infection (fungal infections or<br />bacterial infection) and/or if you have heart problems or AIDS/HIV, see section &lsquo;Taking other<br />medicines&rsquo;<br />Dompy&trade; should be used at the lowest effective dose.<br />While taking Dompy&trade;, contact your doctor if you experience heart rhythm disorders such as<br />palpitations, trouble breathing, loss of consciousness. Treatment with Dompy&trade; should be<br />stopped.<br />Adolescents weighing less than 35kg and children<br />Dompy&trade; should not be given to adolescents 12 years of age and older weighing less than<br />35 kg, or in any children less than 12 years of age, as it is not effective in these age groups.<br />Taking other medicines:<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other<br />medicines. This includes medicines you can buy without a prescription, including herbal<br />medicines. This is because Dompy&trade; can affect the way some other medicines work. Also, some<br />medicines can affect the way Dompy&trade; works.<br />Do not take Dompy&trade; Suspension if you are taking medicines to treat:<br />&bull; fungal infections such as azole anti-fungals, specifically oral ketoconazole, fluconazole or<br />voriconazole<br />&bull; bacterial infections, specifically erythromycin, clarithromycin, telithromycin, moxifloxacin,<br />pentamidine (these are antibiotics)<br />&bull; heart problems or high blood pressure (e.g., amiodarone, dronedarone, quinidine,<br />disopyramide, dofetilide, sotalol, diltiazem, verapamil)<br />&bull; psychoses (e.g., haloperidol, pimozide, sertindole)<br />&bull; depression (e.g., citalopram, escitalopram)<br />&bull; gastro-intestinal disorders (e.g., cisapride, dolasetron, prucalopride)<br />&bull; allergy (e.g., mequitazine, mizolastine)<br />&bull; malaria (in particular halofantrine)<br />&bull; AIDS/HIV (protease inhibitors)<br />&bull; cancer (e.g., toremifene, vandetanib, vincamine)<br />Tell your doctor or pharmacist if you are taking drugs to treat infection, heart problems or<br />AIDS/HIV, the antidepressant nefazadone, levodopa a medicine used to treat Parkinson&rsquo;s<br />symptoms, or aprepitant a medicine used to reduce nausea associated with cancer<br />chemotherapy.<br />Antacids or antisecretory agents should not be taken simultaneously with Dompy&trade; Suspension.<br />Dompy&trade; Suspension should be taken before meals and antacids or antisecretory agents after<br />meals.<br />Dompy&trade; Suspension and apomorphine:<br />Before you use Dompy&trade; Suspension and apomorphine, your doctor will ensure that you tolerate<br />both medicines when used simultaneously.<br />Ask your doctor or specialist for a personalised advice.<br />Please refer to the apomorphine leaflet.<br />It is important to ask your doctor or pharmacist if Dompy&trade; Suspension is safe for you when you<br />are taking any other medicines, including medicines obtained without prescription.<br />Dompy&trade; Suspension with food and drink<br />It is recommended to take Dompy&trade; before meals as when taken after meals the absorption of<br />the medicine is slightly delayed.<br />Pregnancy and breast-feeding<br />Talk to your doctor or pharmacist before taking Dompy&trade; if:<br />&bull; You are pregnant, might become pregnant or think you may be pregnant.<br />&bull; You are breast-feeding. It is best not to take Dompy&trade; if you are breast-feeding. This is<br />because small amounts may pass into the mother&rsquo;s milk. Dompy&trade; should be<br />used during breast feeding only if your physician considers this clearly necessary. Ask your<br />doctor for advice before taking this medicine.<br />Driving and using machines:<br />Dompy&trade; does not affect your ability to drive or use machines.<br />Important information about some of the ingredients of DompyTM Oral Suspension:<br />This medicine contains sorbitol. If you have been told that you cannot digest or tolerate some<br />sugars, talk to your doctor before taking Dompy&trade;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Dompy&trade; Oral Suspension exactly as your doctor has told you. You should check<br />with your doctor or pharmacist if you are not sure.<br />How long can I take Dompy&trade; suspension for?<br />Symptoms usually resolve within 3-4 days of taking this medicine.<br />Do not take Dompy&trade; Oral Suspension for longer than 7 days without consulting your doctor.<br />Taking this medicine<br />&bull; Take this medicine by mouth.<br />Adults and adolescents: take your medicine using the plastic measuring cup provided with<br />Dompy&trade; Oral Suspension. This cup is marked in ml (millilitres) to help you measure out the<br />correct amount of this medicine.<br />This product is not suitable for children under 12 years of age.<br />Take your medicine 15 to 30 minutes before a meal.<br />The usual dose is:<br />Adults and adolescents 12 years of age and older with a body weight of 35 kg or more<br />The usual dose is 10 ml taken up to three times per day, if possible before meals. Do not take<br />more than 30 ml per day.</p><p>People with kidney problems<br />Your doctor may tell you to take a lower dose or to take the medicine less often.<br />If you take more DompyTM than you should:<br />&bull; If you or someone else have used or taken too much Dompy&trade; , contact your doctor,<br />pharmacist, nearest hospital casualty department or the poison centre immediately.<br />Always take the carton and the bottle containing any remaining medicine with you.This is<br />so the doctors know what you have taken.<br />In the events of overdose, symptomatic treatment could be implemented.<br />An ECG monitoring could be undertaken, because of the possibility of heart problem<br />called prolonged QT interval.<br />&bull; The signs of taking more than you should include feeling sleepy, confused,<br />uncontrolled movements (especially in children) which include unusual eye movements,<br />unusual movements of the tongue or abnormal posture (such as a twisted neck).<br />If you forget to take Dompy&trade;:<br />&bull; If you forget to take Dompy&trade;, take it as soon as you remember.<br />&bull; However if it is time for the next dose, skip the missed dose.<br />&bull; Do not take a double dose to make up for a forgotten dose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Dompy&trade; can have side effects, although not everybody gets them.<br />Stop taking Dompy&trade; and see your doctor or go to a hospital straightaway if:<br />&bull; You get swelling of the hands, feet, ankles, face, lips or throat which may cause<br />difficulty in swallowing or breathing. You could also notice an itchy, lumpy rash (hives)<br />or nettle rash (urticaria). This may mean you are having an allergic reaction to Dompy&trade;.<br />&bull; You notice any uncontrolled movements. These include irregular eye movements,<br />unusual movements of the tongue, and abnormal posture such as a twisted neck,<br />trembling and muscle stiffness. This is more likely to happen in children. These<br />symptoms should stop once you stop taking Dompy&trade;.<br />&bull; You have a very fast or unusual heartbeat. This could be a sign of a life-threatening<br />heart problem.<br />&bull; you have a fit (seizure).<br />Other side effects include:<br />Common (affects less than 1 in 10 people)<br />&bull; dry mouth.<br />Uncommon (affects less than 1 in 100 people)<br />&bull; lowering of sexual drive (libido) in men<br />&bull; feeling anxious<br />&bull; feeling drowsy<br />&bull; headaches<br />&bull; diarrhoea<br />&bull; itchy skin. You may also have a rash<br />&bull; unusual production of breast milk in men and women<br />&bull; painful or tender breasts<br />&bull; a general feeling of weakness.<br />Not known (Frequency cannot be estimated from the available data)<br />&bull; Disorders of the cardiovascular system: heart rhythm disorders (rapid or irregular heart<br />beat) have been reported; if this happens, you should stop the treatment immediately.<br />Domperidone may be associated with an increased risk of heart rhythm disorder and<br />cardiac arrest. This risk may be more likely in those over 60 years old or taking doses<br />higher than 30 mg per day. Domperidone should be used at the lowest effective dose.<br />&bull; feeling agitated or irritable<br />&bull; feeling more nervous than usual<br />&bull; abnormal eye movements<br />&bull; inability to urinate<br />&bull; breast enlargement in men<br />&bull; in women, menstrual periods may be irregular or stop<br />&bull; a blood test shows changes in the way your liver is working<br />Some patients who have used Domperidone Suspension for conditions and dosages<br />requiring longer term medical supervision have experienced the following unwanted<br />effects:<br />Restlessness, swollen or enlarged breasts, unusual discharge from breasts, irregular<br />menstrual periods in women, difficulty breastfeeding, depression, hypersensitivity.<br />Talk to your doctor or pharmacist if any of the side effects get serious or last longer than<br />a few days, or if you notice any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not store above 30 &ordm;C.<br />&bull; Do not take Dompy&trade; Oral Suspension after the expiry date stated on the pack.<br />&bull; Advice to be used within 3 months of bottle opening.<br />&bull; Ask your pharmacist how to dispose of medicines you no longer need. Do not dispose of<br />medicines by flushing down a toilet or sink, or by throwing them out with your normal<br />household rubbish. This will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient is domperidone.<br />The other ingredients are: sucrose, avicel RC 591, banana flavor, methylparaben,<br />polysorbate 80, propylparaben, sodium saccharin, sorbitol 70% solution, xanthan gum<br />and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                White to off white suspension, containing visible constituents which may settle as
sediment on storage and can be redispersed on vigorous shaking. It has banana flavor &
sweet taste.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>aMarketing Authorisation Holder and Manufacturer<br />Jamjoom Pharmaceuticals Factory Co.,<br />Jeddah, Makkah Region, Saudi Arabia.<br />Tel: +966-12-6081111 Fax: +966-12-6081222<br />Website: www.jamjoompharma.com<br />Please report adverse drug events to:<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance Centre (NPC):<br />o Fax: +966-11-205-7662<br />o SFDA Call Center: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: https://ade.sfda.gov.sa<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.<br />This leaflet was last reviewed at 09/2024; Version number 05.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 09/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>اسم دوائك ھو دومبى ۱ملجم/مل شراب معلق فى ھذه النشرة). المادة الفعالة فى ھذا الدواء تسمى &trade; ( یسمى دومبى &trade;<br />دومبریدون. ھذا الدواء ینتمى لمجموعة من الأدویة تسمى &quot;مضادات الدوبامین&quot;.<br />یستخدم ھذا الدواء لعلاج الغثیان (الشعور بالغثیان) والقيء لدى البالغین والمراھقین ( ۱۲ عامًا أو أكبر ویزنون<br />۳٥ كجم أو أكثر).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ا: &trade; لا تتناول دومبى<br />یمكنك أن ) &trade; &bull; كان لدیك حساسیة مفرطة لمادة الدومبریدون أو أى من المكونات الأخرى المتواجدة فى معلق دومبى<br />تعرف ھذه المكونات الأخرى في الجزء رقم ٦ من ھذه النشرة). علامات الإصابة بالحساسیة تشمل: طفح جلدى، مشاكل<br />فى البلع أو فى التنفس ، تورم فى الشفتین ، الوجة ، الحلق أو اللسان.<br />&bull; كان لدیك ورم فى الغدة النخامیة.<br />&bull; كان لدیك انسداد أو تمزق فى الأمعاء.<br />&bull; كنت تعانى من براز أسود أو قطرانى اللون أو لاحظت وجود دم مصاحب للبراز. قد یكون ھذا علامة على إصابتك<br />بنزیف فى المعدة أو الأمعاء.<br />&bull; إذا كنت تعاني من مرض الكبد المعتدل أو الحاد<br />&bull; إذا كان تخطیط القلب الكھربائي (مخطط كھربیة القلب) یظھر مشكلة في القلب تسمى &quot;فترة تصحیح كیو تي طویلة&quot;<br />&bull; إذا كنت تعاني أو عانیت من مشكلة أنھ لا یمكن لقلبك ضخ الدم حول جسمك كما ینبغي (حالة تسمى فشل القلب)<br />&bull; إذا كانت لدیك مشكلة تسبب لك إنخفاض مستوى البوتاسیوم أو الماغنسیوم. ، أو إرتفاع البوتاسیوم في دمك<br />&bull; إذا كنت تتناول بعض الأدویة (انظر &quot;تناول أدویة أخرى&quot;)<br />إذا انطبقت علیك إحدى الحالات المذكورة بالأعلى . إذا كنت غیر متأكد، تحدث مع طبیبك أو &trade; لا تتناول دومبى<br />.&trade; الصیدلي قبل البدء فى تناول دومبى<br />التحذیرات و الإحتیاطات<br />قبل تناول ھذا الدواء ، اتصل بطبیبك إذا:<br />إذا:&quot;) &trade; &bull; تعاني من مشاكل في الكبد (اختلال وظائف الكبد أو عجزه) (انظر &quot;لا تتناول دومبى<br />&bull; تعاني من مشاكل في الكلى (ضعف وظائف الكلى أو الفشل).<br />من المستحسن أن تطلب من طبیبك الاستشارة في حالة العلاج لفترة طویلة حیث قد تحتاج إلى تناول جرعة أقل أو تناول<br />ھذا الدواء بشكل متكرر أقل ، وقد یرغب طبیبك في فحصك بانتظام<br />&bull; تتناول دواءً یدعى لیفودوبا ، راجع &quot; تناول الأدویة الأخرى&quot;.<br />&trade; إذا كنت غیر متأكد ما إذا كنت تعانى من إحدى الأشیاء السابق ذكرھا، تحدث مع طبیبك أو الصیدلي. قم تناول دومبى<br />حتى لو كنت قد عانیت من إحدى ھذه المشاكل فى الماضى.<br />من خطر الإصابة بإضطرابات فى دقات القلب أو السكتة القلبیة. یكون ھذا أكثر &trade; من الممكن أن یزید معلق دومبى<br />حدوثا لدى الأشخاص الذین تزید أعمارھم على ٦۰ عام أو الأشخاص الذین یتناولون جرعات تزید على ۳۰ مل جرام<br />یومیا .<br />مع بعض الأدویة. أخبر طبیبك أو الصیدلي إذا كنت تتناول أدویة لعلاج العدوى &trade; یزید الخطر أیضًا عند إعطاء دومبى<br />(الالتھابات الفطریة أو العدوى البكتیریة) و / أو إذا كنت تعاني من مشاكل في القلب أو الإیدز / فیروس نقص المناعة<br />البشریة (راجع قسم &quot; تناول الأدویة الأخرى&quot;.<br />فى أقل جرعة فعالة &trade; ینبغى أن یستخدم دومبى<br />اتصل بطبیبك إذا كنت تعاني من اضطرابات في ضربات القلب مثل الخفقان وصعوبة التنفس ، &trade; أثناء تناول دومبى<br />.&trade; وفقدان الوعي. یجب إیقاف العلاج بدومبى<br />المراھقین الذین یقل وزنھم عن ۳٥ كجم و الأطفال<br />للمراھقین الذین تبلغ أعمارھم ۱۲ عامًا أو أكبر و یقل وزنھم عن ۳٥ كلجم ، أو لدى أي &trade; لا ینبغي إعطاء دومبى<br />أطفال تقل أعمارھم عن ۱۲ عامًا ، لأنھ غیر فعال في ھذه الفئات العمریة.<br />تناول أدویة أخرى<br />یرجى إخبار طبیبك أو الصیدلي إذا كنت تتناول أو تناولت مؤخرا أي أدویة أخرى. ھذا یشمل الأدویة التي یمكنك<br />قد یؤثر على طریقة عمل بعض الأدویة، أیضا &trade; شراؤھا بدون تذكرة طبیة وكذلك الأدویة العشبیة، ھذا لأن دومبى<br />.&trade; بعض الأدویة قد تؤثر على طریقة عمل دومبى<br />و أخبر طبیبك إذا كنت تتناول أدویة لعلاج: &trade; لا تتناول معلق دومبى<br />&bull; الالتھابات الفطریة مثل مضادات الفطریات آزول ، وخاصة الكیتوكونازول عن طریق الفم ، فلوكونازول أو<br />فوركونازول<br />&bull; الالتھابات البكتیریة ، وخاصة الإریثرومیسین ، الكلاریثرومیسین ، التیلثرومیسین ، الموكسیفلوكساسین ، البنتامیدین<br />(ھذه ھي مضادات حیویة)<br />&bull; مشاكل القلب أو ارتفاع ضغط الدم (مثل الأمیودارون ، الدرونیدارون ، الكینیدین ، الدیسوبرامید ، الدوفیتیلید ،<br />السوتالول ، الدیلتیازیم ، الفیرابامیل)<br />&bull; الذھان (مثل ھالوبیریدول ، بیموزید ، سیرتیندول)<br />&bull; الاكتئاب (مثل سیتالوبرام ، إسكیتالوبرام)<br />&bull; الاضطرابات المعدیة المعویة (مثل سیسابرید ، دولاسیترون ، بروكالوبرید)<br />&bull; الحساسیة ( مثل میكیتازین ، میزولاستین)<br />&bull; الملاریا ( خاصة الھالوفانترین)<br />&bull; الإیدز / فیروس نقص المناعة البشریة (مثبطات الأنزیم البروتیني)<br />&bull; السرطان ( مثل توریمیفین ، فاندیتانیب ، فینكامین)<br />أخبر طبیبك أو الصیدلي إذا كنت تتناول أدویة لعلاج العدوى أو مشاكل في القلب أو الإیدز ، أوعقار نافازادون المضاد<br />للاكتئاب ، أو لیفودوبا وھو دواء یستخدم لعلاج أعراض مرض باركنسون ، أو ابریبتانت و ھو دواء یستخدم لتقلیل<br />الغثیان المرتبط بالعلاج الكیمیائي للسرطان.<br />یجب أن یؤخذ .&trade; لا ینبغي أن تؤخذ مضادات الحموضة أو العوامل المضادة للإفراز في وقت واحد مع معلق دومبى<br />قبل الوجبات ومضادات الحموضة أو العوامل المضادة للإفراز بعد الوجبات. &trade; معلق دومبى<br />و الأبومورفین: &trade; معلق دومبى<br />و الأبومورفین ، طبیبك سیتأكد من تحملك كل الأدویة عند استخدامھا في وقت واحد. &trade; قبل استخدام معلق دومبى<br />اسأل طبیبك أو أخصائي للحصول على مشورة شخصیة. یرجى الرجوع إلى نشرة الأبومورفین.<br />آمن لك عند تناول أي أدویة أخرى ، بما في ذلك الأدویة &trade; من المھم أن تسأل طبیبك أو الصیدلي إذا كان معلق دومبى<br />التي تم الحصول علیھا بدون وصفة طبیة.<br />مع الطعام والشراب &trade; معلق دومبى<br />قبل الوجبات حیث أنھ عند تناولھ بعد وجبات الطعام یتأخر امتصاص الدواء قلیلاً. &trade; یوصى بتناول دومبى<br />الحمل و الرضاعة<br />فى الحالات التالیة: &trade; يثدحتإلى طبیبك أو يلدیصلا قبل أن تتناولى دومبى<br />&bull; إذا كنت حاملا ، قد تصبحین حاملا أو تشكین فى كونك حاملا.<br />و ذلك لأنھ قد تنتقل كمیات صغیرة من الدواء إلى &trade; &bull; إذا كنت ترضعین طفلك طبیعیا فمن الأفضل أن لا تتناولى دومبى<br />لبن الأم.<br />أثناء الرضاعة الطبیعیة فقط إذا اعتبر طبیبك ذلك ضروریًا بشكل واضح. اسألي طبیبك &trade; یجب استخدام دومبى<br />للحصول على المشورة قبل تناول ھذا الدواء.<br />قیادة المركبات و تشغیل الآلات<br />على قدرتك على القیادة أو استخدام الآلات. &trade; لا یؤثر دومبى<br />&trade; معلومة ھامة عن بعض المكونات الموجودة فى معلق دومبى<br />ھذا الدواء یحتوى على السوربیتول . إذا قیل لك أنھ لا یمكنك ھضم بعض السكریات ، أخبر طبیبك بھذا قبل البدء فى<br />.&trade; تناول دومبى<br />&trade; ۳. كیف</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما أخبرك طبیبك تماما. یجب علیك مراجعة طبیبك أو الصیدلي الخاص بك إذا كنت غیر متأكد &trade; قم دائما بتناول دومبى<br />من طریقة الاستخدام .<br />؟ &trade; كم من الوقت یمكن تناول معلق دومبى<br />٤ أیام من تناول ھذا الدواء. - عادة ما تتلاشى الأعراض خلال ۳<br />لمدة أطول من ۷ أیام دون استشارة طبیبك. &trade; لا تأخذ معلق دومبى<br />تناول ھذا الدواء<br />&bull; تناول ھذا الدواء عن طریق الفم.<br />ھذا .&trade; البالغون والمراھقون: تناول ھذا الدواء باستخدام الكوب البلاستیكى المدرَج الموجود فى عبوة معلق دومبى<br />الكوب مدرَج بالمل لیترات لیساعدك على تحدید المقدار الصحیح الذى یجب تناولھ من الدواء.<br />ھذا المنتج غیر مناسب للأطفال دون سن ۱۲ عامًا.<br />تناول الدواء قبل تناول الطعام من ۱٥ إلى ۳۰ دقیقة.<br />الجرعة المعتادة ھي:<br />البالغون والمراھقون بعمر ۱۲ سنة وما فوق ویبلغ وزن الجسم ۳٥ كیلو جرام أو أكثر<br />الجرعة المعتادة ھي ۱۰ مل تؤخذ ثلاث مرات في الیوم ، إذا كان ذلك ممكنا قبل الوجبات. لا تأخذ أكثر من ۳۰ مل<br />یومیا.<br />الأشخاص الذین یعانون من مشاكل فى الكلى<br />أو تتناولھ عدد أقل من المرات. &trade; من الممكن أن یطلب منك طبیبك أن تتناول جرعة أقل من دومبى<br />أكثر مما یجب: &trade; إذا تناولت دومبى<br />فاتصل بطبیبك أو الصیدلي أو قسم الحوادث بأقرب ، &trade; &bull; إذا تناولت أنت أو أي شخص آخر أكثر مما یجب من دومبى<br />مستشفى أو مركز للسموم على الفور.<br />خذ معك علبة الدواء و والزجاجة التي تحتوي على أي دواء متبقٍ. ھذا یعرف الأطباء ما الذي أخذتھ.</p><p>في حالة الجرعة الزائدة ، قد یتم علاج الأعراض.<br />المطولة. QT یمكن إجراء مراقبة تخطیط القلب ، بسبب احتمال حدوث مشكلة في القلب تدعى فترة<br />أكثر مما یجب تشمل الشعور بالنعاس ، التشوش ، الحركات الا إرادیة ) &trade; &bull; العلامات التى تدل على أنك تناولت دومبى<br />خاصة عند الأطفال (والتى تشمل الحركات الغیر عادیة للعین ، اللسان أو وضعیة وقوف غیر طبیعیة مثل التواء الرقبة.<br />: &trade; إذا نسیت أن تتناول دومبى<br />قم بأخذه بمجرد أن تتذكر. &trade; &bull; إذا نسیت أن تتناول دومبى<br />&bull; لكن إذا كان الوقت قد حان للجرعة التالیة ، لا تأخذ الجرعة المنسیة.<br />&bull; لا تأخذ جرعة مضاعفة لتعویض الجرعة المنسیة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><br />لكنھا لا تصیب كل الأشخاص. &trade; كما ھو الحال مع كل الأدویة ، من المحتمل ظھور أعراض جانبیة لدومبى<br />و توجھ فى الحال إلى طبیبك أو إلى أقرب مستشفى عند: &trade; أوقف تناول دومبى<br />&bull; حدوث تورم فى الیدین ،القدمین ،الكعبین ،الوجھ ، الشفتین أو الحلق مما قد یسبب صعوبة فى البلع أو التنفس .من<br />&trade; الممكن أیضا أن تلاحظ ظھور طفح جلدى مثیر للحكة . ھذا یعنى أنك تعانى من حساسیة لدومبى<br />&bull; ملاحظتك حدوث أى حركات لا إرادیة تشمل حركات غیر منتظمة للعینین ،حركات غیر عادیة للسان أو وضعیة<br />وقوف غیر طبیعیة مثل التواء الرقبة ،ارتجاف و تیبس العضلات و یكون ھذا أكثر حدوثا فى الأطفال .ھذه الأعراض<br />&trade; یجب أن تتوقف بمجرد توقف تناولك لدومبى<br />&bull; شعورك بضربات قلب سریعة جدا أو غیر عادیة . ھذا قد یكون علامة على إصابتك بمشكلة فى القلب تھدد الحیاة.<br />&bull; لدیك نوبة (تشنج).<br />الأعراض الجانبیة الأخرى تشمل:<br />شائعة (تصیب أقل من ۱ من كل ۱۰ أشخاص)<br />&bull; فم جاف.<br />غیر شائعة (تصیب أقل من شخص من كل ۱۰۰ شخص)<br />&bull; إنخفاض الدافع الجنسي (الرغبة الجنسیة) لدى الرجال<br />&bull; الشعور بالقلق<br />&bull; الشعور بالنعاس<br />&bull; الصداع<br />&bull; إسھال<br />&bull; حكة في الجلد. قد یكون لدیك أیضا طفح جلدي<br />&bull; إنتاج غیر طبیعي من حلیب الأم لدى الرجال والنساء<br />&bull; ألم أو لین الثدیین<br />&bull; شعور عام بالضعف.<br />غیر معروف معدل تكرارھا (لا یمكن تقدیر التردد من البیانات المتاحة)<br />&bull; اضطرابات في نظام القلب والأوعیة الدمویة: تم الإبلاغ عن اضطرابات ضربات القلب (سرعة ضربات القلب أو<br />عدم انتظام) ؛ إذا حدث ھذا ، یجب علیك إیقاف العلاج على الفور. قد یرتبط الدومبیریدون بزیادة خطر اضطراب<br />ضربات القلب والسكتة القلبیة. یكون ھذا الخطر أكثر عرضة لمن ھم فوق ٦۰ عامًا أو الذین یتناولون جرعات<br />تزید عن ۳۰ ملجم یومیا. یجب استخدام دومبیریدون بأقل جرعة فعالة. ینبغى أن یستخدم دومبیریدون بأقل جرعة فعالة.<br />&bull; شعور بالھیاج و سرعة الإنفعال.<br />&bull; شعور بالعصبیة أكثر من المعتاد.<br />&bull; حركات العین غیر طبیعیة<br />&bull; عدم القدرة على التبول<br />&bull; تضخم الثدى لدى الرجال.<br />&bull; عند السیدات ،قد تصبح الدورة الشھریة غیر منتظمة أو قد تنقطع.<br />&bull; اختبار الدم یظھر تغیرات في طریقة عمل الكبد<br />عانى بعض المرضى الذین استخدموا معلق دومبریدون للحالات والجرعات التي تتطلب إشرافًا طبیًا على المدى الطویل<br />من الآثار غیر المرغوب فیھا التالیة:<br />الأرق ، تورم أو تضخم الثدیین ، إفرازات غیر اعتیادیة من الثدي ، فترات الحیض غیر المنتظمة لدى النساء ، صعوبة<br />في الرضاعة الطبیعیة ، الاكتئاب ، فرط الحساسیة.<br />تحدث مع طبیبك أو الصیدلي الخاص إذا أصبحت إحدى الأعراض الجانبیة خطیرة أو استمرت لمدة تزید عن بضعة<br />أیام، أو لاحظت حدوث أیة أعراض جانبیة أخرى غیر المذكورة فى ھذه النشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>٥. كیف تقوم بحفظ دومبى<br />&bull; یحفظ بعیداً عن متناول و رؤیة الأطفال.<br />&bull; یحفظ فى درجة حرارة لا تزید عن ۳۰ درجة مئویة.<br />بعد انتھاء فترة صلاحیتھا المكتوب على العلبة. &trade; &bull; لا تتناول معلق دومبى<br />&bull; ینصح بالإستخدام في فترة ۳ أشھر من فتح الزجاجة.<br />&bull; اسأل الصیدلي عن طریقة التخلص من الأدویة التي لم تعد بحاجة إلیھا .لا ینبغي التخلص من الأدویة عبر إلقائھا فى<br />بالوعات الصرف أو فى مخلفات المنزل . ستساعد ھذه التدابیر في حمایة البیئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما ھي مكونات معلق دومبى<br />۱ ملجم/مل شراب معلق یحتوى على دومبریدون (كمادة فعالة). &trade; دومبى<br />المواد الأخري: السكروز، آفیسیل سى آر ٥۹۱ ، نكھة الموز، میثیل بارابین، بولیسوربیت ۸۰ ، بروبیل بارابین، سكرین<br />الصودیوم، محلول سوربیتول ۷۰ ٪، صمغ زنتان وماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">و ما ھو محتوى العلبة &trade; ما ھو شكل معلق دومبى<br />معلق لونھ أبیض إلي مائل للأبیض یحتوي علي مكونات مرئیة التي قد تترسب مع التخزین ویمكن اعادة توزیعھا بالرج<br />القوي للزجاجة. لھ نكھة الموز و طعم حلو.<br />متوفر في زجاجة كھرمانیة اللون بھا ۲۰۰ مل.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">شركة مصنع جمجوم للأدویة،<br />جدة، المملكة العربیة السعودیة.<br />+۹٦٦-۱۲- ھاتف: ٦۰۸۱۱۱۱<br />+۹٦٦-۱۲- فاكس: ٦۰۸۱۲۲۲<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبیھ:<br />&bull; المملكة العربیة السعودیة:<br />:(NPC) المركز الوطني للتیقظ الدوائي<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />مركز اتصال الھیئة العامة للغذاء والدواء: ۱۹۹۹۹ o<br />npc.drug@sfda.gov.sa : برید إلكتروني o<br />https://ade.sfda.gov.sa : الموقع الالكتروني o<br />&bull; دول الخلیج الأخرى:<br />- الرجاء الاتصال بالمؤسسات و الھیئات الوطنیة في كل دولة.<br />۲۰۲٤ . رقم النسخة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            09-2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dompy Oral Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml of Dompy Oral suspension contains 1 mg domperidone.
For Full list of Excipients please refer to section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral suspension
White to off white suspension, containing visible constituents which may settle as sediment on
storage and can be redispersed on vigorous shaking. It has banana flavor & sweet taste, filled
in amber glass bottles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone is indicated for the relief of the symptoms of nausea and vomiting.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone should be used at the lowest effective dose for the shortest duration necessary to<br />control nausea and vomiting.<br />It is recommended to take oral domperidone before meals. If taken after meals, absorption of the<br />drug is somewhat delayed.<br />Patients should try to take each dose at the scheduled time. If a scheduled dose is missed, the<br />missed dose should be omitted and the usual dosing schedule resumed. The dose should not be<br />doubled to make up for a missed dose.</p><p>Usually, the maximum treatment duration should not exceed one week.<br />Adults and adolescents (12 years of age and older and weighing 35 kg or more)<br />10 ml (of oral suspension containing domperidone 1mg per ml) up to three times per day with a<br />maximum daily dose of 30 ml per day.<br />Oral domperidone should be taken before meals/feeding. If taken after meals absorption of the<br />drug is somewhat delayed.<br />Hepatic Impairment<br />Domperidone is contraindicated in moderate or severe hepatic impairment (see section 4.3).<br />Dose modification in mild hepatic impairment is however not needed (see section 5.2).<br />Renal Impairment<br />Since the elimination half-life of domperidone is prolonged in severe renal impairment, on<br />repeated administration, the dosing frequency of domperidone should be reduced to once or<br />twice daily depending on the severity of the impairment, and the dose may need to be reduced.<br />Such patients on prolonged therapy should be reviewed regularly (see sections 4.4 and 5.2)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Domperidone is contraindicated in the following situations:
• Known hypersensitivity to domperidone or any of the excipients
• Prolactin-releasing pituitary tumour (prolactinoma).
• When stimulation of the gastric motility could be harmful, e.g., in patients with gastrointestinal
haemorrhage, mechanical obstruction or perforation.
• In patients with moderate or severe hepatic impairment (see section 5.2).
• In patients who have known existing prolongation of cardiac conduction intervals, particularly
QTc, patients with significant electrolyte disturbances or underlying cardiac diseases such as
congestive heart failure.
• Co-administration with QT-prolonging drugs.
• Co-administration with potent CYP3A4 inhibitors (regardless of their QT prolonging effects).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cardiovascular effects:<br />Domperidone has been associated with prolongation of the QT interval on the electrocardiogram.<br />During post-marketing surveillance, there have been very rare cases of QT prolongation and<br />torsades de pointes in patients taking domperidone. These reports included patients with<br />confounding risk factors, electrolyte abnormalities and concomitant treatment which may have<br />been contributing factors (see section 4.8).<br />Epidemiological studies showed that domperidone was associated with an increased risk of<br />serious ventricular arrhythmias or sudden cardiac death (see section 4.8). A higher risk was<br />observed in patients older than 60 years, patients taking daily doses greater than 30 mg, and<br />patients concurrently taking QT-prolonging drugs or CYP3A4 inhibitors.<br />Domperidone should be used at the lowest effective dose in adults and adolescents 12 years of<br />age and older.<br />Domperidone is contraindicated in patients with known existing prolongation of cardiac<br />conduction intervals, particularly QTc, in patients with significant electrolyte disturbances<br />(hypokalaemia, hyperkalaemia, hypomagnesaemia), or bradycardia, or in patients with<br />underlying cardiac diseases such as congestive heart failure due to increased risk of ventricular<br />arrhythmia (see section 4.3.). Electrolyte disturbances (hypokalaemia, hyperkalaemia,<br />hypomagnesaemia) or bradycardia are known to be conditions increasing the proarrythmic risk.<br />Treatment with domperidone should be stopped if signs or symptoms occur that may be<br />associated with cardiac arrhythmia, and the patients should consult their physician.<br />Patients should be advised to promptly report any cardiac symptoms.</p><p>Renal impairment<br />The elimination half-life of domperidone is prolonged in severe renal impairment. For repeated<br />administration, the dosing frequency of domperidone should be reduced to once or twice daily<br />depending on the severity of the impairment, and the dose may need to be reduced. Such patients<br />on prolonged therapy should be reviewed regularly (see section 5.2).<br />Excipients<br />The oral suspension contains sorbitol (E420). Patients with rare hereditary problems of fructose<br />intolerance should not take this medicine. The oral suspension includes propylhydroxybenzoate<br />(E216) and methylhydroxybenzoate (E218) which may cause allergic reactions (possibly<br />delayed).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Antacids or antisecretory agents should not be taken simultaneously with oral formulations of<br />domperidone as they lower the oral bioavailability of domperidone. Domperidone should be<br />taken before meals and antacids or antisecretory agents after meals.<br />The main metabolic pathway of domperidone is through CYP3A4. In vitro data suggest that the<br />concomitant use of drugs that significantly inhibit this enzyme may result in increased plasma<br />levels of domperidone.<br />Increased risk of occurrence of QT-interval prolongation, due to pharmacodynamic and/or<br />pharmacokinetic interactions.<br />Concomitant use of the following substances is contraindicated<br />QTc prolonging medicinal products<br />&bull; anti-arrhythmics class IA (e.g., disopyramide, hydroquinidine, quinidine)<br />&bull; anti-arrhythmics class III (e.g., amiodarone, dofetilide, dronedarone, ibutilide, sotalol)<br />&bull; certain anti-psychotics (e.g., haloperidol, pimozide, sertindole)<br />&bull; certain anti-depressants (e.g., citalopram, escitalopram)</p><p>&bull; certain antibiotics (e.g. , erythromycin, levofloxacin, moxifloxacin, spiramycin)<br />&bull; certain antifungal agents (e.g., pentamidine)<br />&bull; certain antimalarial agents (in particular halofantrine, lumefantrine)<br />&bull; certain gastro-intestinal medicines (e.g., cisapride, dolasetron, prucalopride)<br />&bull; certain antihistaminics (e.g., mequitazine, mizolastine)<br />&bull; certain medicines used in cancer (e.g., toremifene, vandetanib, vincamine)<br />&bull; certain other medicines (e.g., bepridil, diphemanil, methadone) (see section 4.3).<br />Potent CYP3A4 inhibitors (regardless of their QT prolonging effects), i.e.:<br />&bull; protease inhibitors<br />&bull; systemic azole antifungals<br />&bull; some macrolides (erythromycin, clarithromycin, telithromycin)<br />(see section 4.3).<br />Concomitant use of the following substances is not recommended<br />Moderate CYP3A4 inhibitors i.e. diltiazem, verapamil and some macrolides. (see section 4.3)<br />Concomitant use of the following substances requires caution in use<br />Caution with bradycardia and hypokalaemia-inducing drugs, as well as with the following<br />macrolides involved in QT-interval prolongation: azithromycin and roxithromycin<br />(clarithromycin is contra-indicated as it is a potent CYP3A4 inhibitor).<br />The above list of substances is representative and not exhaustive.<br />Separate in vivo pharmacokinetic/pharmacodynamic interaction studies with oral ketoconazole<br />or oral erythromycin in healthy subjects confirmed a marked inhibition of domperidone&#39;s<br />CYP3A4 mediated first pass metabolism by these drugs.<br />With the combination of oral domperidone 10mg four times daily and ketoconazole 200mg twice<br />daily, a mean QTc prolongation of 9.8 msec was seen over the observation period, with changes<br />at individual time points ranging from 1.2 to 17.5 msec. With the combination of domperidone<br />10mg four times daily and oral erythromycin 500mg three times daily, mean QTc over the</p><p>observation period was prolonged by 9.9 msec, with changes at individual time points ranging<br />from 1.6 to 14.3 msec. Both the Cmax and AUC of domperidone at steady state were increased<br />approximately three-fold in each of these interaction studies. In these studies domperidone<br />monotherapy at 10mg given orally four times daily resulted in increases in mean QTc of 1.6<br />msec (ketoconazole study) and 2.5 msec (erythromycin study), while ketoconazole monotherapy<br />(200mg twice daily) led to increases in QTc of 3.8 and 4.9 msec, respectively, over the<br />observation period.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy:<br />There are limited post-marketing data on the use of domperidone in pregnant women. Studies in<br />animals have shown reproductive toxicity at maternally toxic doses (see section 5.3).<br />Domperidone should only be used during pregnancy when justified by the anticipated therapeutic<br />benefit.<br />Breast-feeding:<br />Domperidone is excreted in human milk and breast-fed infants receive less than 0.1 % of the<br />maternal weight-adjusted dose. Occurrence of adverse effects, in particular cardiac effects cannot<br />be excluded after exposure via breast milk. A decision should be made whether to discontinue<br />breast-feeding or to discontinue/abstain from domperidone therapy taking into account the<br />benefit of breast feeding for the child and the benefit of therapy for the woman. Caution should<br />be exercised in case of QTc prolongation risk factors in breast-fed infants.</p><p>Fertility<br />There are no data on the effects of domperidone on human fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone has no or negligible influence on the ability to drive and use machines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tabulated list of adverse reactions<br />The safety of domperidone was evaluated in clinical trials and in postmarketing experience. The<br />clinical trials included 1275 patients with dyspepsia, gastro-oesophageal reflux disorder<br />(GORD), Irritable Bowel Syndrome (IBS), nausea and vomiting or other related conditions in 31<br />double-blind, placebo-controlled studies. All patients were at least 15 years old and received at<br />least one dose of domperidone (domperidone base). The median total daily dose was 30 mg<br />(range 10 to 80 mg), and median duration of exposure was 28 days (range 1 to 28 days). Studies<br />in diabetic gastroparesis or symptoms secondary to chemotherapy or parkinsonism were<br />excluded.<br />The following terms and frequencies are applied:<br />very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare<br />(&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), Where frequency can not be estimated from<br />clinical trials data, it is recorded as &ldquo;Not known&rdquo;.</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr><td colspan="" rowspan=""><p><strong>System Organ Class</strong></p></td><td colspan="3" rowspan=""><p><strong>Adverse Drug Reaction</strong></p><p><strong>Frequency</strong></p></td></tr><tr><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p><strong>Common</strong></p></td><td colspan="" rowspan=""><p><strong>Uncommon</strong></p></td><td colspan="" rowspan=""><p><strong>Not known</strong></p></td></tr><tr><td colspan="" rowspan=""><p><strong>Immune system disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Anaphylactic reaction (including anaphylactic shock)</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Psychiatric disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Loss of libido</p><p>Anxiety</p></td><td colspan="" rowspan=""><p>Agitation</p><p>Nervousness</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Nervous system disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Somnolence</p><p>Headache</p></td><td colspan="" rowspan=""><p>Convulsion</p><p>Extrapyramidal disorder</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Eye disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Oculogyric crisis</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Cardiac disorders (see section 4.4)</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Ventricular arrhythmias</p><p>Sudden cardiac death</p><p>QTc prolongation</p><p>Torsade de Pointes</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Gastrointestinal disorders</strong></p></td><td colspan="" rowspan=""><p>Dry mouth</p></td><td colspan="" rowspan=""><p>Diarrhoea</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Skin and subcutaneous tissue disorder</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Rash</p><p>Pruritus</p></td><td colspan="" rowspan=""><p>Urticaria</p><p>Angioedema</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Renal and urinary disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Urinary retention</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Reproductive system and breast disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Galactorrhoea</p><p>Breast pain</p><p>Breast tenderness</p></td><td colspan="" rowspan=""><p>Gynaecomastia</p><p>Amenorrhoea</p></td></tr><tr><td colspan="" rowspan=""><p><strong>General disorders and administration site conditions</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Asthenia</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Investigations</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Liver function test abnormal</p><p>Blood prolactin increased</p></td></tr></tbody></table><p>In 45 studies where domperidone was used at higher dosages, for longer duration and for<br />additional indications including diabetic gastroparesis, the frequency of adverse events (apart<br />from dry mouth) was considerably higher. This was particularly evident for pharmacologically<br />predictable events related to increased prolactin. In addition to the reactions listed above,<br />akathisia, breast discharge, breast enlargement, breast swelling, depression, hypersensitivity,<br />lactation disorder, and irregular menstruation were also noted.</p><p>To reports any side effect(s):<br />&bull; Saudi Arabia<br />-The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npcG<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />Symptoms of overdosage may include agitation, altered consciousness, convulsions,<br />disorientation, somnolence and extrapyramidal reactions.<br />Treatment<br />There is no specific antidote to domperidone, but in the event of overdose, standard symptomatic<br />treatment should be given immediately. Gastric lavage as well as the administration of activated<br />charcoal, may be useful. ECG monitoring should be undertaken, because of the possibility of QT<br />interval prolongation. Close medical supervision and supportive therapy is recommended.<br />Anticholinergic, anti-parkinson drugs may be helpful in controlling the extrapyramidal reactions.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Propulsives, ATC code: A03FA03<br />Mechanism of action<br />Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not<br />readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal<br />side effects are very rare, but domperidone promotes the release of prolactin from the pituitary.<br />Its anti-emetic effect may be due to a combination of peripheral (gastrokinetic) effects and<br />antagonism of dopamine receptors in the chemoreceptor trigger zone, which lies outside the<br />blood-brain barrier in the area postrema. Animal studies, together with the low concentrations<br />found in the brain, indicate a predominantly peripheral effect of domperidone on dopamine<br />receptors.<br />Studies in man have shown oral domperidone to increase lower oesophaegeal pressure, improve<br />antroduodenal motility and accelerate gastric emptying. There is no effect on gastric secretion.<br />In accordance with ICH&mdash;E14 guidelines, a thorough QT study was performed. This study<br />included a placebo, an active comparator and a positive control and was conducted in healthy<br />subjects with up to 80 mg per day 10 or 20 mg administered 4 times a day of domperidone. This<br />study found a maximal difference of QTc between domperidone and placebo in LS-means in the<br />change from baseline of 3.4 msec for 20 mg domperidone administered 4 times a day on Day 4.<br />The 2-sided 90 % CI (1.0 to 5.9 msec) did not exceed 10 msec. No clinically relevant QTc<br />effects were observed in this study when domperidone was administered at up to 80 mg/day (i.e.,<br />more than twice the maximum recommended dosing).<br />However, two previous drug-drug interaction studies showed some evidence of QTc<br />prolongation when domperidone was administered as monotherapy (10 mg 4 times a day).The<br />largest time-matched mean difference of QTcF between domperidone and placebo was 5.4 msec<br />(95 % CI: -1.7 to 12.4) and 7.5 msec (95 % CI: 0.6 to 14.4), respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Domperidone is rapidly absorbed after oral administration, with peak plasma concentrations<br />occurring at approximately 1 hr after dosing. The Cmax and AUC values of domperidone<br />increased proportionally with dose in the 10 mg to 20 mg dose range. A 2- to 3-fold<br />accumulation of domperidone AUC was observed with repeated four times daily (every 5 hr)<br />dosing of domperidone for 4 days.<br />The low absolute bioavailability of oral domperidone (approximately 15%) is due to an extensive<br />first-pass metabolism in the gut wall and liver. Although domperidone&#39;s bioavailability is<br />enhanced in normal subjects when taken after a meal, patients with gastro-intestinal complaints<br />should take domperidone 15-30 minutes before a meal. Reduced gastric acidity impairs the<br />absorption of domperidone. Oral bioavailability is decreased by prior concomitant administration<br />of cimetidine and sodium bicarbonate. The time of peak absorption is slightly delayed and the<br />AUC somewhat increased when the oral drug is taken after a meal.<br />Distribution<br />Oral domperidone does not appear to accumulate or induce its own metabolism; a peak plasma<br />level after 90 minutes of 21 ng/ml after two weeks oral administration of 30 mg per day was<br />almost the same as that of 18 ng/ml after the first dose. Domperidone is 91-93% bound to plasma<br />proteins. Distribution studies with radiolabelled drug in animals have shown wide tissue<br />distribution, but low brain concentration. Small amounts of drug cross the placenta in rats.<br />Biotransformation<br />Domperidone undergoes rapid and extensive hepatic metabolism by hydroxylation and Ndealkylation.<br />In vitro metabolism experiments with diagnostic inhibitors revealed that CYP3A4<br />is a major form of cytochrome P-450 involved in the N-dealkylation of domperidone, whereas<br />CYP3A4, CYP1A2 and CYP2E1 are involved in domperidone aromatic hydroxylation.</p><p>Excretion<br />Urinary and faecal excretions amount to 31 and 66% of the oral dose respectively. The<br />proportion of the drug excreted unchanged is small (10% of faecal excretion and approximately<br />1% of urinary excretion). The plasma half-life after a single oral dose is 7-9 hours in healthy<br />subjects but is prolonged in patients with severe renal insufficiency.<br />Hepatic impairment<br />In subjects with moderate hepatic impairment (Pugh score 7 to 9, Child-Pugh rating B), the AUC<br />and Cmax of domperidone is 2.9- and 1.5-fold higher, respectively, than in healthy subjects. The<br />unbound fraction is increased by 25%, and the terminal elimination half-life is prolonged from<br />15 to 23 hours. Subjects with mild hepatic impairment have a somewhat lower systemic<br />exposure than healthy subjects based on Cmax and AUC, with no change in protein binding or<br />terminal half-life. Subjects with severe hepatic impairment were not studied. Domperidone is<br />contraindicated in patients with moderate or severe hepatic impairment (see section 4.3).<br />Renal impairment<br />In subjects with severe renal insufficiency (creatinine clearance &lt;30ml/min/1.73m2) the<br />elimination half-life of domperidone is increased from 7.4 to 20.8 hours, but plasma drug levels<br />are lower than in healthy volunteers. Since very little unchanged drug (approximately 1%) is<br />excreted via the kidneys, it is unlikely that the dose of a single administration needs to be<br />adjusted in patients with renal insufficiency.<br />However, on repeated administration, the dosing frequency should be reduced to once or twice<br />daily depending on the severity of the impairment, and the dose may need to be reduced.<br />Paediatric population<br />No pharmacokinetic data are available in the paediatric population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Electrophysiological in vitro and in vivo studies indicate an overall moderate risk of<br />domperidone to prolong the QT interval in humans. In in vitro experiments on isolated cells<br />transfected with hERG and on isolated guinea pig myocytes, exposure ratios ranged between 26-<br />47-fold, based on IC50 values inhibiting currents through IKr ion channels in comparison to the<br />free plasma concentrations in humans after administration of the maximum daily dose of 10 mg<br />administered 3 times a day. Safety margins for prolongation of action potential duration in in<br />vitro experiments on isolated cardiac tissues exceeded the free plasma concentrations in humans<br />at maximum daily dose (10 mg administered 3 times a day) by 45-fold. Safety margins in in<br />vitro pro-arrhythmic models (isolated Langendorff perfused heart) exceeded the free plasma<br />concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by 9- up to<br />45-fold. In in vivo models the no effect levels for QTc prolongation in dogs and induction of<br />arrhythmias in a rabbit model sensitized for torsade de pointes exceeded the free plasma<br />concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by more<br />than 22-fold and 435-fold, respectively. In the anesthetized guinea pig model following slow<br />intravenous infusions, there were no effects on QTc at total plasma concentrations of 45.4<br />ng/mL, which are 3-fold higher than the total plasma levels in humans at maximum daily dose<br />(10 mg administered 3 times a day). The relevance of the latter study for humans following<br />exposure to orally administered domperidone is uncertain.<br />In the presence of inhibition of the metabolism via CYP3A4 free plasma concentrations of<br />domperidone can rise up to 3-fold.<br />At a high, maternally toxic dose (more than 40 times the recommended human dose), teratogenic<br />effects were seen in the rat. No teratogenicity was observed in mice and rabbits.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sucrose<br />Polysorbate 80<br />Xanthan Gum<br />Sodium Sacchrain<br />Sorbitol 70 % solution<br />Methylparaben<br />Propylparaben<br />Avicel RC 591<br />Banana Flavour<br />Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 month
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C. Advice to be used within 3 month of bottle opening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Immediate Container: Amber coloured glass bottles 200 ml.<br />Secondary Container: Carton label &amp; PIL</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company
P.O. Box 6267
Jeddah 21442
Tel: +966-12-6081111
Fax: +966-12-6081222.
Kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May - 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>